User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

1st International Meeting of Diabetes and Bone

1st International Meeting of Diabetes and Bone
  • Cardiometabolic
    Endocrinology and metabolism
  • Diabetes
International conference by Excemed
Friday, Nov 7 - Saturday, Nov 8 2014
Rome, Italy

Event format



The official language of this live educational workshop will be English

Simultaneous translation is provided from English to Italian and vice versa.

Registration status

This live educational event is free of charge. Please email if you have any questions.

Places are available on a first come first served basis.


This meeting is aimed at all branches of medicine from clinicians to basic scientists interested in diabetes and osteoporosis. The objective would be to bridge the gap and explore the pathophysiology linking these diseases and forge an alliance with all health care professionals involved in treating the huge number of patients suffering from diabetes and osteoporosis.


Diabetes is one of the fasting growing diseases in the western world and is becoming a huge problem in the emerging economic power houses such as India and Asia and particularly China. The numbers of patients is  are staggering and the rate of newly diagnosed diabetics continues to grow. This is especially as Type 2 diabetes mellitus (DMT2) is associated with obesity which in itself is becoming a global health problem.

Osteoporosis is another disease which is increasing due to  aging populations and an accompanying increase in fractures.  There are approximately 1.5 million fractures per year in the USA .The population suffering low bone density is about 44 million, of which about 14 million are osteoporotic. The cost of the disease has been estimated to be in the region of $ 22 billion annually. The mortality after a hip fracture is around 50 % in the first year. Morbidity is accompanied also includes loss of independence. Despite effective drugs reducing the fracture burden by about 50-60% the disease is still not recognized ,diagnosed, or treated.

This meeting is aimed at all branches of medicine from clinicians to basic scientists interested in both diseases. The objective would be to bridge the gap and explore the pathophysiology linking these diseases and forge an alliance with all health care professionals involved in treating the huge number of patients suffering from diabetes and osteoporosis.

Learning objectives

By attending this live educational meeting the learners will be able to:

  • Assess fracture risk in diabetic patients
  • Utilise the latest pathophysiology of bone fragility in diabetes
  • Utilise the latest diagnostic tools and treatment options for diabetes related fractures

Accreditation details

The Italian National Commission for Continuing Medical Education has accredited this SIF SRL event n. 1841- 105289 (provider reference number - event reference number),“1st International Meeting of Diabetes and Bone” (7-8 November, 2014, Rome, Italy) for N. 8 (eight) Italian CME credits.

This programme is endorsed by SID (Società Italiana di Diabetologia), SIE (Società Italiana di Endocrinologia) and SIOMMMS (Società Italiana dell’ Osteoporosi del Metabolismo Minerale e delle Malattie dello Scheletro).

Additional information

This programme has been designed in partnership with the Università Campus Bio-Medico di Roma (UCBM).

Scientific programme

Friday 7 November


10:00: Registration

10:45: Welcome and Introduction,
S. Epstein, USA, N. Napoli, Italy, P. Pozzilli, Italy


Session I


Chairpersons: S. Epstein, US, G. Isaia, Italy

11:00: New concepts and latest research directions in the pathophysiology of diabetes

P.Pozzilli, Italy      

11:30: Osteoblasts in diabetic patients, too lazy or just insulin resistant? 
R. Civitelli, USA

12:00: The obesity epidemic, and the central role of adipose tissue in metabolic disorder

Marco Baroni, Italy

12:30: Diabetes and fractures. Is it a global health problem?
B. Abrahamsen, Denmark

13:00: Lunch


Session II


Chairpersons: R. Civitelli, USA, L. Gennari, Italy

14:00: Neuro endocrine, GUT hormones and Bone
L. Baggio, USA

14:30: Prevention of diabetes through bariatric surgery
G. Mingrone, Italy

15:00: Vitamin D and diabetes
R. de Jongh, Belgium

15.30: Pathophysiology diabetic bone disease
A. Schwartz, USA

16:00 Coffee Break


Session III The treatment of bone fragility in diabetic patients


Chairperson: S. Migliaccio, Italy

16:30 :GLP-1 analogues, from diabetes treatment to bone anabolism
N. Napoli, Italy

17:00: Implications for the treatment of osteoporosis in the diabetic patient
D. Black, USA

17.30: Design of clinical trials to evaluate skeletal benefit and risk in diabetic patients
H. Bone, USA

18.00: Clinical Round Table and open debate
A. Schwartz, USA;  I. Chiodini,Italy;  N. Napoli, Italy;  D. Black,USA; H. Bone,USA;  P. Falaschi, Italy;  S.  Epstein, USA

18.30: End of the first day


Saturday, 8 November


Session IV


Chairpersons: D.Lauro,Italy and S.Migliaccio, Italy

09:00: Animal models of diabetic bone disease. Advantages and disadvantages
L.McCabe, USA

09:30: Latest advances in technology to assess diabetic bone disease
D. Hans, Switzerland

10.00: Bone histomorphometry and bone markers

D. Dampster, USA

10.30 Coffee Break


Session V


Chairpersons: D.Dempster, USA and L.Gennari, Italy

11:00: Post transplant bone disease in diabetics
S. Epstein, USA

11:30: The role of the anti-ageing gene Sirtuin I in diabetes and osteoporosis
R. Dresner-Pollack, Israel

Lilly symposium: Not CME accredited

12:00: Does anabolic therapy have a role in the treatment of diabetic bone disease
N. Napoli, Italy

12:30: Concluding remarks

13:00: End of the Meeting

CME provider

Società di Formazione Internazionale SRL  

Scientific Provider No. 1841


Nicola Napoli

University Campus Bio-Medico di Roma (UCBM)
Rome, Italy
Washington University
St Louis, United States

Sol Epstein

Mt. Sinai School of Medicine
New York, United States

Paolo Pozzilli

Endocrinology and metabolic diseases Department
University Campus Bio-Medico di Roma (UCBM)
Rome, Italy


Bo Abrahamsen 

Institute of Clinical Research, SDU Research Centre for Ageing and Osteoporosis, 

Department of Medicine M, Glostrup Hospital (Nord)

Glostrup, Denmark

Laurie Baggio

Mt. Sinai Hospital

Samuel Lunenfeld Research Institute

Toronto, Ontario, Canada

Marco Baroni

Clinica Medica

University of Rome “La Sapienza”

Rome, Italy

Dennis Black

University of California

San Francisco (UCSF)

San Francisco, California, USA

Henry Bone

Michigan Bone and Mineral Clinic PC

University of Michigan

Detroit, USA

Iacopo Chiodini

Ospedale Maggiore Policlinico IRCCS 

Milan, Italy

Roberto Civitelli

Division of Bone and Mineral Diseases

Musculoskeletal Research Center

Washington University School of Medicine

St. Louis, Missouri, USA

Renate T. de Jongh

VU Medical Center

Amsterdam, The Netherlands

David Dempster

College of Physicians and Surgeons of Columbia University

Regional Bone Cente,Helen Hayes Hospital

New York State Department of Health

New York, USA

Rivka Dresner-Pollak

Hadassah-Hebrew University Medical Center 

Jerusalem, Israel

Sol Epstein

Mt. Sinai School of Medicine  

New York, NY, USA

Paolo Falaschi

University of “La Sapienza”

Rome, Italy

Luigi Gennari

University of Siena

“Santa Maria alle Scotte” Hospital

Siena, Italy

Andrea Giustina

University of Brescia

Brescia, Italy

Didier Hans

University of Lausanne

Lausanne, Switzerland

Giancarlo Isaia

Unit of Geriatrics and Metabolic Bone

Diseases. Molinette Hospital

AO Città della Salute e della Scienza di Torino 

School of Geriatric Medicine

University of Torino


Italian Osteoporosis and Metabolic Bone

Diseases Society (SIOMMMS)

Torino, Italy

Davide Lauro

University of “Tor Vergata”

Rome, Italy

Andrea Lenzi

Univeristy of “La Sapienza”

Rome, Italy

Laura McCabe

Biomedical Imaging Research Center

Michigan State University

East Lansing, MI, USA

Silvia Migliaccio

"Foro Italico" Universi ty

Rome, Italy

Geltrude Mingrone

Policlinico Gemelli

Università Cattolica del Sacro Cuore

Rome, Italy

Nicola Napoli 

University Campus Bio-Medico di Roma (UCBM)

Rome, Italy

Paolo Pozzilli

University Campus Bio-Medico di Roma (UCBM)

Rome, Italy

Ann Schwartz

University of California

San Francisco (UCSF)

San Francisco, California, USA


EXCEMED- Excellence in Medical Education
Salita di San Nicola da Tolentino, 1/b00187 Rome, Italy

Programme Manager: Giovanna Rossi

T +39-(0)6-420 413 252 - F +39-(0)6-420 413 677


EXCEMED is a Swiss Foundation with headquarters in 14, Rue du Rhône, 1204 Geneva, Switzerland

Endocrinology and metabolism